The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NOVT | -35.44% | -1.73% | -0.35% | +609% |
| S&P | +15.06% | +95.03% | +14.29% | +431% |
Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products. The Vision segment offers a range of medical grade technologies, including medical insufflators, pumps and related disposables, surgical displays and operating room integration technologies, optical data collection and machine vision technologies, radio frequency identification technologies, thermal printers, spectrometry technologies, and embedded touch screen solutions. The Precision Motion segment includes optical encoders, precision motor and motion control technology, air bearing spindles, and precision machined components to customers. The company was founded in 1968 and is headquartered in Bedford, MA.
One familiar name tops the list, but the others may surprise you.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $241.05M | 2.2% |
| Gross Profit | $99.88M | 3.2% |
| Gross Margin | 41.43% | 0.4% |
| Market Cap | $4.64B | -20.8% |
| Market Cap / Employee | $1.55M | 0.0% |
| Employees | 3K | 3.4% |
| Net Income | $4.50M | -67.3% |
| EBITDA | $43.06M | 1.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $109.91M | 11.6% |
| Accounts Receivable | $161.20M | 11.2% |
| Inventory | 168.1 | 5.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $497.90M | -4.6% |
| Short Term Debt | $15.51M | 1.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 4.22% | -0.5% |
| Return On Invested Capital | 6.10% | -0.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $12.40M | -64.9% |
| Operating Free Cash Flow | $15.93M | -60.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 105.75 | 86.12 | 65.53 | 76.62 | -19.05% |
| Price to Book | 8.66 | 7.39 | 6.16 | 6.02 | -29.85% |
| Price to Sales | 6.90 | 5.82 | 4.86 | 4.91 | -25.01% |
| Price to Tangible Book Value | -127.79 | -109.11 | -189.55 | 1557.55 | -3378.67% |
| Price to Free Cash Flow TTM | 61.10 | 39.88 | 31.30 | 37.57 | -21.80% |
| Enterprise Value to EBITDA | 137.89 | 123.90 | 114.05 | 118.38 | -20.70% |
| Free Cash Flow Yield | 1.6% | 2.5% | 3.2% | 2.7% | 27.88% |
| Return on Equity | 8.7% | 9.0% | 9.7% | 8.2% | -12.81% |
| Total Debt | $514.29M | $471.00M | $442.53M | $513.41M | -4.44% |
NOVT earnings call for the period ending March 31, 2020.
NOVT earnings call for the period ending December 31, 2019.
NOVT earnings call for the period ending September 30, 2019.
NOVT earnings call for the period ending June 30, 2019.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
